natgillin/translations-raw huggingface dataset:
The strength of Stalevo that the
Za vsa navodila o
The strength of Vokanamet that you will take varies depending on your condition and the amount of canagliflozin and metformin needed to control your blood sugar.
Jakost zdravila Vokanamet, ki ga boste jemali je odvisna od vaše bolezni in od tega, koliko kanagliflozina in metformina potrebujete za uravnavanje koncentracije sladkorja v krvi.
The strengths are 0.5 mg, 1 mg and 2 mg.
Tablete so na voljo v treh jakostih: 0,5 mg, 1 mg in 2 mg.
The Stribild renal educational brochure shall contain the following key safety messages:
Izobraževalna brošura o obravnavi ledvic za zdravilo Stribild mora vsebovati naslednja ključna varnostna sporočila:
The strict conditions put in place to prevent pregnancies and the exposure of unborn children to thalidomide must be met by all men and women taking the medicine.
Vsi moški in ženske, ki jemljejo to zdravilo, morajo izpolnjevati stroge pogoje, določene za preprečevanje nosečnosti in izpostavljanja nerojenih otrok talidomidu.
The strong CYP3A inducers rifampicin and herbal preparations containing St John’s wort (Hypericum perforatum).
Močni induktorji CYP3A: rifampicin in zdravila rastlinskega izvora, ki vsebujejo šentjanževko (Hypericum perforatum).
The studies also confirmed the effect of a booster injection at 15 months after the first vaccination (the booster for Ibrax is recommended every 6 months).
Raziskave so potrdile tudi učinkovitost poživitvenih injekcij 15 mesecev po prvem cepljenju (poživitveni odmerek zdravila Ibraxion je priporočljiv vsakih 6 mesecev).
The studies also demonstrated susceptibility of many solid tumour cell lines to cytarabine, particularly after longer periods of exposure to cytarabine.
Študije so pokazale tudi občutljivost velikega števila celičnih linij parenhimskih tumorjev za citarabin, zlasti po daljših obdobjih izpostavljenosti citarabinu.
The studies also established that there is no apparent relationship between the dosage and the body weight of the dog – therefore the dosing has to be decided on an individual basis.
Študije so pokazale tudi, da ni očitne povezave med odmerjanjem in telesno maso psice – zato je treba odmerek določiti posamezno.
The studies also looked at the effect of Aubagio on the changes in the patients’ level of disability and showed that the risk of disability getting worse was reduced by 30% in comparison with placebo after around two and a half years (132 weeks) of treatment.
V študijah so proučevali tudi učinek zdravila Aubagio na spremembo stopnje nezmožnosti bolnikov in ugotovili, da se je po dveh letih in pol (132 tednih) zdravljenja tveganje za poslabšanje nezmožnosti zmanjšalo za 30 % v primerjavi s placebom.
The studies also looked at the number of patients with a target number of stems cells collected and in whom the stems cells were successfully engrafted (started growing and producing normal blood cells).
Študije so proučevale tudi število bolnikov z zbranim ciljnim številom matičnih celic, pri katerih so bile matične celice uspešno vcepljene (začele so rasti in tvoriti normalne krvne celice).
The studies also showed a benefit of Dexdor in reducing the duration of mechanical ventilation.
Študije so pokazale tudi koristi zdravila Dexdor pri skrajševanju časa mehanične ventilacije.
The studies also showed an improvement in symptoms such as breathlessness and wheezing.
V študijah so opazili tudi izboljšanje simptomov, kot so zasoplost in hropenje.
The studies also showed that Senshio was effective in restoring the vaginal environment including its acidity and thickness of tissues.
Študiji sta pokazali tudi, da je zdravilo Senshio učinkovito obnovilo nožnično okolje, tudi njegovo kislost in debelino tkiv.
The studies also showed that the vaccine can be used in pregnant and lactating sheep and cattle.
Pokazale so tudi, da se cepivo lahko uporabi pri brejih ovcah in kravah ter tistih v laktaciji.
The studies assessed the number of bleeding episodes that occurred and rated BeneFIX’s effectiveness using a scale from ‘no response’ to ‘excellent’.
V študijah so beležili število krvavitev, ki so se pojavile, in vrednotili učinkovitost zdravila BeneFIX na podlagi lestvice z ocenami od „ni odziva“ do „odličen odziv“.
The studies compared Diacomit capsules or sachets with placebo (a dummy treatment), when they were added to the children’s existing treatment with clobazam and valproate.
V študijah so učinkovitost kapsul ali vrečk zdravila Diacomit primerjali z učinkovitostjo placeba (zdravila brez zdravilne učinkovine), ki so jih dodajali otrokovemu obstoječemu zdravljenju s klobazamom in valproatom.
The studies compared Eylea (given either as 0.5 mg every four weeks, 2 mg every four weeks or 2 mg every eight weeks, all after three initial monthly doses) with ranibizumab, another treatment for AMD which was given by injection into the eye every four weeks.
V študijah so zdravilo Eylea (dano bodisi v odmerku 0,5 mg vsake štiri tedne, 2 mg vsake štiri tedne ali 2 mg vsakih osem tednov, v vseh primerih po treh začetnih mesečnih odmerkih) primerjali z ranibizumabom, drugo obliko zdravljenja starostne degeneracije makule, ki se injicira v oko vsake štiri tedne.
The studies compared Stayveer with placebo (a dummy treatment), when they were added to standard treatment.
V študijah so zdravilo Stayveer primerjali s placebom (zdravilom brez zdravilne učinkovine), ki so ju dodajali standardnemu zdravljenju.
The studies compared the ability of the vaccines to trigger the production of antibodies (immunogenicity) by comparing antibody levels before injection and three weeks afterwards.
V študijah so primerjali učinkovitost cepiv pri sprožanju tvorbe protiteles (imunogenost) tako. da so primerjali ravni protiteles pred injiciranjem in tri tedne po njem.
The studies compared Tracleer with placebo (a dummy treatment), when they were added to standard treatment.
V študijah so primerjali zdravilo Tracleer s placebom (zdravilom brez zdravilne učinkovine), kadar so ju dodajali standardnemu zdravljenju.
The studies comparing the chewable tablets with the capsules showed that the amount of undigested fat passed out in patients’ stools was the same after taking either formulation.
V študijah, v katerih so primerjali žvečljive tablete s kapsulami, so bolniki po jemanju ene in druge formulacije v blatu izločili enako količino neprebavljene maščobe.
The studies consisted of two phases – a pre-antiviral treatment phase and an antiviral treatment phase.
Študije so bile izvedene v dveh fazah – faza brez protivirusnega zdravljenja in faza protivirusnega zdravljenja.
The studies described below (GOAL, TORCH and SMART) were carried out with this same fixed-dose combination, salmeterol xinafoate and fluticasone propionate, but studied a previously authorised product; the studies described were not carried out with Aerivio Spiromax.
Študije, opisane v nadaljevanju (GOAL, TORCH in SMART), so bile izvedene z enako fiksno kombinacijo odmerkov salmeterolijevega ksinafoata in flutikazonpropionata, vendar s predhodno odobrenim zdravilom; opisane študije niso bile izvedene z zdravilom Airexar Spiromax.
The studies described were carried out with a previously authorised product available in three different strengths; the studies were not carried out with Aerivio Spiromax.
Opisane študije so bile izvedene s predhodno odobrenim zdravilom, ki je bilo na voljo v treh različnih jakostih; študije niso bile izvedene z zdravilom Aerivio Spiromax.
The studies described were carried out with a previously authorised product available in three different strengths; the studies were not carried out with Aerivio Spiromax.
Opisane študije so bile izvedene s predhodno odobrenim zdravilom, ki je bilo na voljo v treh različnih jakostih; študije niso bile izvedene z zdravilom Airexar Spiromax.
The studies did not include a control group (Targetin was not compared to another medicine or to placebo).
Študiji nista vključevali kontrolne skupine (zdravila Targretin niso primerjali z drugim zdravilom ali s placebom).
The studies either recruited patients who were being treated with chemotherapy (two studies) or used patient populations in which ESAs are not indicated: anaemia in patients with cancer not receiving chemotherapy, and head and neck cancer patients receiving radiotherapy.
V študiji so bili vključeni bodisi bolniki, ki so prejemali kemoterapijo (dve študiji), ali bolniki, pri katerih uporaba ESA ni bila indicirana: anemija pri bolnikih z rakom, ki niso prejemali kemoterapije, in bolniki z rakom glave in vratu, ki so prejemali radioterapijo.
The studies examined if the infection was cured in the days following treatment (7 to 28 days after treatment depending on the type of infection).
V študijah so preverjali, ali se je okužba v dnevih po zdravljenju (7 do 28 dni po zdravljenju, odvisno od vrste okužbe) pozdravila.
The studies in infants and older children showed that although Synflorix produced a lower antibody response than the comparator vaccine, it fulfilled pre-defined criteria and was considered acceptable in this group.
Študije so pokazale, da je zdravilo Synflorix, čeprav je povzročilo manjši odziv protiteles pri dojenčkih in starejših otrocih kot primerjalno cepivo, izpolnilo vnaprej določena merila in je bilo opredeljeno kot sprejemljivo za to skupino.
The studies in patients with macular oedema following CRVO also looked at the effects of treatment on an as-needed basis after 24 weeks.
V študijah makularnega edema, ki je posledica zapore osrednje mrežnične vene so proučevali tudi učinke zdravljenja, ki se daje po potrebi po 24 tednih.
The studies in patients with MMN showed that Kiovig was effective in maintaining muscle strength and reducing disability.
Študije pri bolnikih z multifokalno motorično nevropatijo so pokazale, da je zdravilo Kiovig učinkovito pri ohranjanju mišične moči in zmanjševanju bolnikove prizadetosti.
The studies included 213 exposed patients; 150 adolescents or adult patients without inhibitors from the age of 12 years (≥150 exposure days) and 63 paediatric patients without inhibitors below 12 years of age (≥50 exposure days).
Zajela so 213 izpostavljenih bolnikov; 150 mladostnikov ali odraslih bolnikov brez zaviralcev, starejših od 12 let (≥ 150 dni izpostavljenosti), in 63 pediatričnih bolnikov brez zaviralcev, mlajših od 12 let (≥ 50 dni izpostavljenosti).
The studies included adult patients for the most part, with children included in studies for Crohn’s disease, plaque psoriasis, polyarticular juvenile idiopathic arthritis and enthesitis-related arthritis.
Večina bolnikov v teh študijah je bila odraslih, otroci so bili vključeni v študije Crohnove bolezni, psoriaze v plakih, poliartikularnega juvenilnega idiopatskega artritisa in artritisa, povezanega z entezitisom.
The studies included dogs of various ages, different breeds and weights, which were naturally infected, or could become infected, with parasitic gastrointestinal roundworms or coccidia.
V študije so bili vključeni psi različnih starosti, pasem in telesne mase, ki so bili naravno okuženi ali bi se lahko okužili z zajedavskimi gastrointestinalnimi valjastimi črvi ali kokcidijami.
The studies included young and adult cats of various breeds, but not young kittens.
V študije so vključili mlade in odrasle mačke različnih pasem, ne pa muck.
The studies involved cats and dogs of different age groups, genders and breeds.
Študije so vključevale mačke in pse različnih starostnih skupin, spolov in pasem.
The studies lasted between six and 52 weeks and the main measure of effectiveness was the change in blood pressure during either the resting phase of the heartbeat (‘diastolic’) or when the chambers of the heart were contracting (‘systolic’).
Študije so trajale od šest do 52 tednov, glavno merilo učinkovitosti pa je bila sprememba krvnega tlaka med mirovalno fazo srčnega utripa (diastolični tlak) ali med krčenjem komor srca (sistolični tlak).
The studies lasted between six and 52 weeks and the main measure of effectiveness was the change in blood pressure during either the resting phase of the heartbeat (‘diastolic’) or when the chambers of the heart were contracting (‘systolic’).
Študije so trajale od šest do 52 tednov, glavno merilo učinkovitosti pa je bila sprememba krvnega tlaka med mirovalno fazo srčnega utripa (diastolični tlak) ali med krčenjem srčnih komor srca (sistolični tlak).
The studies looked at Crixivan taken on its own or in combination with other antiviral medicines, and compared it with other antiviral medicines (zidovudine, didanosine and lamivudine).
V študijah so proučevali zdravilo Crixivan kot samostojno zdravilo ali v kombinaciji z drugimi protivirusnimi zdravili in ga primerjali z drugimi protivirusnimi zdravili (zidovudinom, didanozinom in lamivudinom).
The studies looked at how many patients responded to treatment (i.e. patients who had no cancer cells in the breast after surgery).
Opazovali so, koliko bolnikov, pri katerih po kirurškem posegu ni bilo rakavih celic v dojkah, se je pozitivno odzvalo na zdravljenje.
The studies looked at the
V študijah so preučevali učinkovitost
The studies looked at the ability of the vaccine to trigger the production of antibodies (‘immunogenicity’) against the flu virus.
V teh dveh študijah so proučevali sposobnost cepiva Aflunov, da sproži nastajanje protiteles („imunogenost“) proti virusu gripe.
The studies looked at the ability of the vaccine to trigger the production of antibodies (‘immunogenicity’) in line with the CHMP criteria for prepandemic vaccines.
V teh študijah so proučevali sposobnost cepiva, da sproži nastajanje protiteles („imunogenost“) v skladu z merili CHMP za prepandemska cepiva.
The studies looked at the effectiveness of Improvac in triggering an immune response by measuring the levels of antibodies against GnRF and the levels of testosterone (the male sex hormone) in the pigs’ blood at several time points before slaughter.
V študijah so raziskovali učinkovitost zdravila Improvac pri sprožanju imunskega odziva z merjenjem ravni protiteles proti GnRF in raven testosterona (spolnega hormona samcev) v krvi prašičev večkrat pred zakolom.
The studies looked at the number of patients who had died 30 to 35 days after treatment, and at the number of patients who had heart failure (an inability of the heart to pump enough blood around the body) or a stroke.
V študijah so proučevali število bolnikov, ki so umrli v 30–35 dneh po zdravljenju, ter število bolnikov, ki so imeli srčno popuščanje (stanje, pri katerem srce ne zmore črpati dovolj krvi po telesu) ali so doživeli kap.
The studies looked at the numbers of patients who died, had an amputation, and had new thromboembolic (clotting) complications.
V študijah so ugotavljali, koliko bolnikov je umrlo,
The studies looked at whether the infections had been cured or had improved.
V študijah so proučevali, ali je bila okužba ozdravljena oziroma ali se je stanje izboljšalo.
The studies measured how many patients had a complete response, which was defined as no vomiting and no need for any other medication to control nausea and vomiting in the 24 hours after the operation.
V študijah so beležili, pri koliko bolnikih je prišlo do popolnega odziva, kar pomeni, da niso bruhali oziroma niso potrebovali nobenih zdravil za obvladanje slabosti in bruhanja v 24 urah po operaciji.
The studies measured the level in the blood of a substance called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
V študijah so merili raven snovi v krvi, imenovane glikozilirani hemoglobin (HbA1c), ki kaže, kako dobro je raven glukoze v krvi uravnana.
The studies measured the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled, and ‘fasting’ blood glucose levels (measured when the patient had not eaten for at least eight hours).
V študijah so merili raven snovi v krvi, imenovane glikozilirani hemoglobin (HbA1c), ki kaže, kako učinkovito je raven glukoze v krvi nadzorovana, in glukoze v krvi bolnika na tešče (izmerjene vsaj osem ur po zadnjem obroku).
The studies measured the number of cases of flu, proven by laboratory tests.
V študijah so beležili število primerov gripe, dokazanih z laboratorijskimi preiskavami.
The studies measured the ‘fasting’ blood glucose levels (measured when the patient had not eaten for at least eight hours), or the levels of a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
V okviru študij so merili raven glukoze na tešče (izmerjeno, ko bolnik najmanj osem ur ni zaužil hrane) ali koncentracijo snovi, imenovane glikozilirani hemoglobin (HbA1c), ki kaže, kako dobro je glukoza v krvi uravnana.
The studies of pancreatic disease involved 292 patients, and compared the effectiveness of TESLASCAN-enhanced MRI with that of ‘spiral CT’, another diagnostic method used to detect pancreatic lesions.
V študije bolezni trebušne slinavke je bilo vključenih 292 bolnikov, v njih pa so primerjali učinkovitost magnetno resonančnega slikanja, ojačanega z zdravilom TESLASCAN, ter „spiralne računalniške tomografije (CT)“, ki je še ena diagnostična metoda za odkrivanje lezij trebušne slinavke.
The studies showed that Bexsero was effective at stimulating an immune response to N. meningitidis group B. The study in children also showed that a single booster dose of Bexsero at 12 months of age produced a stronger immune response in children who had already received Bexsero than the first of two ‘catch-up’ doses in children of the same age who had not.
Študije so pokazale, da je cepivo Bexsero učinkovito pri spodbujanju imunskega odziva na bakterijo N. meningitidis skupine B. Študija pri otrocih je pokazala tudi, da je enkratni poživitveni odmerek cepiva Bexsero pri starosti 12 mesecev povzročil močnejši imunski odziv pri otrocih, ki so že prejeli cepivo Bexsero, kot prvi od dveh naknadnih odmerkov pri otrocih iste starosti, ki zdravila prej niso prejeli.
The studies showed that Leucofeligen FeLV/RCP provided protection against the diseases listed above.
Študije so pokazale, da je cepivo Leucofeligen FeLV/RCP zagotovilo zaščito proti zgoraj naštetim boleznim.
The studies showed that Leucogen provided protection against FeLV infection.
Študije so pokazale, da cepivo Leucogen zagotavlja zaščito proti okužbi z FeLV.
The studies showed that Nimenrix was as effective as the comparator vaccines in stimulating an immune response against all four types of N. meningitidis polysaccharides in people of different age groups.
Študije so pokazale, da je cepivo Nimenrix pri spodbujanju imunskega odziva proti vsem štirim vrstam polisaharidov bakterije N. meningitidis pri ljudeh različnih starostnih skupin enako učinkovito kot primerjalna cepiva.
The studies showed that Procox was superior to the comparator medicines or placebo in all studies.
Vse študije so pokazale, da je zdravilo Procox boljše od primerjalnih zdravil ali placeba.
The studies showed that the birds which receive the vaccine develop antibodies against the H5 subtype of the avian influenza virus.
Raziskave so pokazale, da ptice, ki prejmejo cepivo, tvorijo protitelesa proti virusu aviarne influence podtipa H5.
The studies showed that the first injection has a limited effect, but the second injection is followed by the production of antibodies against GnRF.
Študije so pokazale, da ima prva injekcija omejen učinek, drugi injekciji pa sledi proizvodnja protiteles proti GnRF.
The studies showed that the medicine was more effective than placebo at improving exercise capacity and was as effective as atenolol and amlodipine.
V študijah so dokazali, da je bilo to zdravilo pri izboljšanju vadbene zmogljivosti učinkovitejše od placeba in enako učinkovito kot atenolol ter amlodipin.
The studies showed that the vaccine is safe for both sheep and cattle from two and a half months of age onwards.
Študije so pokazale, da je cepivo varno za ovce in govedo v starosti od 2,5 meseca dalje.
The studies showed that the vaccine is safe for sheep and cattle and that it reduces the signs of the disease and prevents viraemia in animals from one month of age that are infected with bluetongue virus serotypes 1, 4 and 8.
Študije so pokazale, da je cepivo varno za uporabo pri ovcah in govedu ter da zmanjšuje simptome bolezni in preprečuje viremijo pri živalih, starejših od enega meseca, ki so okužene s serotipi 1, 4 in 8 virusa bolezni modrikastega jezika.
The studies showed that vaccination of the mothers with Circovac can reduce the incidence of lesions associated with PCV2 infection in the lymphoid tissues of their piglets.
Študije so pokazale, da lahko cepljenje samic s cepivom Circovac zmanjša pogostost lezij, povezanih z okužbo s cirkovirusom PCV2, v limfnih tkivih njihovih pujskov.
The studies showed that Zolvix is effective against infections of all of the major gastrointestinal nematodes, including effectiveness against strains of parasites resistant to the currently available broad-spectrum anthelmintics.
Študije so pokazale, da je zdravilo Zolvix učinkovito proti okužbam vseh pomembnejših želodčno- črevesnih glist, vključno s sevi zajedavcev, ki so odporni na trenutno razpoložljive širokospektralne antihelmintike.
The studies were nearly identical in design, with few exceptions including an intermediate dose group (1,197 mg/day) in PIPF-004.
Študiji sta bili z nekaj izjemami, na primer s skupino, ki je v študiji PIPF– 004 dobivala srednje velik odmerek (1197 mg/dan), po zasnovi skoraj identični.
The studies were still ongoing at the time of the medicine’s assessment.
Študije so v času ocenjevanja zdravila še potekale.
The study (SP3) in Japanese patients compared pirfenidone 1800 mg/day (comparable to 2403 mg/day in the US and European populations of PIPF-004/006 on a weight-normalised basis) with placebo (N=110, N=109, respectively).
Študija (SP3), ki je vključevala japonske bolnike, je primerjala pirfenidon v odmerku 1800 mg/dan (kar je v okviru normalizirane porazdelitve telesne mase primerljivo z odmerkom 2403 mg/dan pri populacijah ZDA in Evrope, ki sta jih vključevali študiji PIPF–004/006) s placebom (n = 110 oz. n = 109).
The study also failed to demonstrate non-inferiority of the rate of combined graft loss, missing survival data, or death for the sirolimus conversion group compared to the CNI continuation group.
V študiji tudi niso dokazali neinferiornosti glede pogostnosti kombinirane izgube presadka, manjkajočih podatkov o preživetju ali smrti za skupino s prehodom na sirolimus v primerjavi s skupino, ki je nadaljevala s CNI.
The study also found that patients treated with Keytruda lived longer than patients who received ipilimumab.
V študiji so prav tako ugotovili, da je bilo skupno preživetje bolnikov, zdravljenih z zdravilom Keytruda, daljše kot pri bolnikih, ki so prejemali ipilimumab.
The study also looked at the number of women who had fractures elsewhere in the body, including in the hip.
V študiji so proučevali tudi število žensk, pri katerih je prišlo do zloma drugih kosti v telesu, vključno s kolkom.
The study also looked at the proportion of dogs that had no seizures.
Prav tako so v študiji ugotavljali delež psov brez epileptičnih napadov.
The study also measured the change in the patients’ symptoms, assessed in several ways including using a standard scale (called a CNS-LS score which ranges from 7 to 35).
V študiji so merili tudi spremembe simptomov pri bolnikih, ki so jih ocenjevali na več načinov, vključno s standardno lestvico (imenovano lestvica CNS-LS z rezultati od 7 do 35).
The study also showed a reduction of over 90% in the signs of flea allergy dermatitis in dogs treated with either Vectra 3D or the comparator product.
V študiji so zabeležili tudi več kot 90-odstotno zmanjšanje znakov alergijskega dermatitisa, ki ga povzročajo bolhe, pri psih, ki so prejeli zdravilo Vectra 3D ali primerjalno zdravilo.
The study also showed that Vectra Felis was effective as an aid in the treatment of flea allergy dermatitis in cats.
Prav tako je študija pokazala, da je bilo zdravilo Vectra Felis učinkovito kot pomoč pri zdravljenju alergijskega dermatitisa pri mačkah, ki ga povzročajo bolhe.